Interim Report 1 January – 30 June 2016 3 months ended 30

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 16, 2016 at 1:30 AM

Interim Report 1 January – 30 June 2016

3 months ended 30 June 2016 · Local currency sales increased by 17% and Euro sales increased by 3% to €309.6m (€301.0m). · Number of active consultants decreased by 5% to 2.9m. · EBITDA amounted to €40.6m (€29.6m). · Operating margin was 9.9% (7.2%, adjusted* 8.3%), impacted by -390 bps from currencies, and operating profit €30.8m (€21.7m, adjusted* €25.0m ). · Net profit was €18.1m (€9.1m, adjusted** €11.9m) and diluted EPS €0.32 (€0.16, adjusted** €0.21). · Cash flow from operating activities was €35.8m (€25.3m). · The year to date sales development is approximately 14% in local currency and the development in the third quarter to date is approximately 12% in local currency. *Adjusted for non-recurring items of €3.2m in the second quarter 2015 **Adjusted for additional non-recurring items of (€0.5m) in the second quarter 2015 6 months ended 30 June 2016 · Local currency sales increased by 14% and Euro sales increased by 1% to €615.4m (€608.9m). · EBITDA amounted to €68.3m (€52.6m). · Operating margin was 8.4% (6.4%, adjusted* 6.9%), impacted by -390 bps from currencies, and operating profit was €51.9m (€39.0m, adjusted* €42.2m). · Net profit was €28.8m (€20.4m, adjusted** €23.1m) and diluted EPS €0.51 (€0.37, adjusted** €0.42). · Cash flow from operating activities amounted to €57.3m (€49.4m). *Adjusted for non-recurring items of €3.2m during the period 2015 **Adjusted for additional non-recurring items of (€0.5m) during the period 2015 Significant events after the end of the quarter · Oriflame will prepay $14.1m of the Private Placement debt during the third quarter 2016, corresponding to a cash outflow of €9.9m. CEO Magnus Brännström comments “We are pleased with the healthy sales development during the second quarter where we report Euro growth despite strong currency headwinds, partly fueled by positive timing and a strong start of the quarter. The solid performance in Asia & Turkey and Latin America continued and further improvements could be seen in Europe, while the situation in Africa was continuously challenging. CIS experienced local currency growth in the quarter although margin improvement challenges remain. The third quarter has started in a promising way, although many of our markets continue to be volatile and we face highly uncertain geopolitical and macroeconomic conditions. We continue to execute on our strategic priorities to further strengthen our position and efficiency going forward.” Conference call for the financial community The company will host a conference call on Tuesday, 16 August 2016 at 11.00 CET. Participant access numbers: DK: +45 35445575 FI: +35 8981710493 UK: +44 2030089802 NO: +47 23500254 SE: +46 856642691 US: +18558315948 The conference call will also be audio web cast in “listen-only” mode through Oriflame’s website: www.oriflame.com or through http://oriflame -ir.creo.se/160816 16 August 2016 Magnus Brännström Chief Executive Officer For further information, please contact: Magnus Brännström, Chief Executive Officer Tel: +41 798 263 754 Gabriel Bennet, Chief Financial Officer Tel: +41 798 263 769 Nathalie Redmo, Investor Relations Manager Tel: +41 799 220 173 This information is information that Oriflame Holding AG is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:15 CET on August 16, 2016. Oriflame Holding AG Bleicheplatz 3, CH-8200 Schaffhausen, Switzerland www.oriflame.com Company registration no CHE-134.446.883

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pre-Owned Jet Inventory Rises; Price Trends Unclear

October's Pre-Owned Aircraft Inventory: A Mixed Bag Nothing like leafing through October's data on pre-owned jets and feeling your stomach do that weird flip-flop. Inventory's nudging up, but it's still on its knees compared to last year's numbers. According to Sandhills Global's fresh aviation market reports, we got an increase in what's available on platforms like...

Gildan Class Action: What Investors Should Know

Playing Hardball: Gildan Faces Serious Claims Gildan Activewear Inc. (NYSE:GIL) isn't just dealing with wardrobe malfunctions; it's knee-deep in a class action lawsuit that's got investors on edge. The allegations? Accusations of deceptive practices like channel stuffing, which supposedly jazzed up their financials by moving unsold products through distribution channels...

Mount St. Mary's University Climbs in College Rankings

Moving Up the Rankings Ladder Mount St. Mary's University has been making waves not only on campus but in the highly competitive world of college rankings. The institution has managed to climb the ranks in the 2026–27 U.S. News & World Report Best Colleges rankings, a feat that's not just some idle happenstance. The Numbers Speak If you've been paying attention, the...

Radiation Oncology Text Earns Doody's 2026 Nod

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Preventing Dental Issues in Kids: Valuable Tips Shared

Pediatric Dental Challenges Under the Microscope When it comes to kids and dental health, we're talking about the fundamentals—the kind that sticks around and makes a difference in their future pearly whites. None of that flashy tech gizmo stuff, just straight-on strategies for resilient chompers. Cavities, gum irritation, early tooth alignment—these are the everyday...

VS Pharmtech Enhances Cancer Drug Efficiency, Eyes IPO

Revolutionizing Cancer Care, One Dose at a Time Now, here's a twist worth chewing over your morning coffee: VS Pharmtech isn't concocting some newfangled miracle drug but is instead jazzing up the old ones. Their creation, VS-101, isn't just another treatment—it's a radiosensitizer designed to make existing therapies more potent without the toxic baggage. The Science...

Lands' End Brings Holiday Magic to Chicago

Something about the first chill in the air can spark that holiday vibe, and Lands' End sure knows how to bottle it. They’ve concocted a hefty dose of festive magic in Chicago with their weekend shindig, a mix of holiday nostalgia, community cheer, and retail bravado. Now, I'm not here to just wax poetic about winter hats and fuzzy pajamas, but this event's got a twinkle...

QORAI CORP's Q4 Nexus: A New AI Frontier

Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...

Frederick's VFW Post Thrives with New Facility Launch

The Power of Building a Legacy There I was, watching the home the VFW built not just with nails and beams, but conviction. In a world where construction and legacy often don't speak the same language, the Frederick VFW Post 3285 is flipping the script. We're looking at a story about real, tangible impact—not in the P&Ls but in actual lives. Brick by Brick: A...

LaserAway Opens 241st Clinic, Marks 20-Year Milestone

LaserAway's New Chapter in Paramus Out of the glitz of Los Angeles and into the hustle of Paramus, LaserAway's latest clinic isn't just a ribbon-cutting ceremony—it's a milestone in the aesthetic dermatology space. Boasting its 241st location, LaserAway is marking twenty years of relentless expansion without ever closing a single clinic. Now that's a track record that'd...